Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2021. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4023730010 | Soybean oil refined 200 mg/mL emulsion for infusion | en | Synonym | Active | Only initial character case insensitive | SNOMED CT core module |
| 5073141012 | Product containing precisely Glycine max oil refined 200 milligram/1 milliliter conventional release emulsion for infusion (clinical drug) | en | Fully specified name | Active | Only initial character case insensitive | SNOMED CT core module |
| 5073142017 | Soya bean oil refined 200 mg/mL emulsion for infusion | en | Synonym | Active | Only initial character case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely Glycine max oil refined 200 milligram/1 milliliter conventional release emulsion for infusion (clinical drug) | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely Glycine max oil refined 200 milligram/1 milliliter conventional release emulsion for infusion (clinical drug) | Has concentration strength numerator value | 200 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely Glycine max oil refined 200 milligram/1 milliliter conventional release emulsion for infusion (clinical drug) | Has concentration strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely Glycine max oil refined 200 milligram/1 milliliter conventional release emulsion for infusion (clinical drug) | Has concentration strength denominator unit | Milliliter | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely Glycine max oil refined 200 milligram/1 milliliter conventional release emulsion for infusion (clinical drug) | Has concentration strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely Glycine max oil refined 200 milligram/1 milliliter conventional release emulsion for infusion (clinical drug) | Has precise active ingredient | Glycine max oil refined | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely Glycine max oil refined 200 milligram/1 milliliter conventional release emulsion for infusion (clinical drug) | Has basis of strength substance | Glycine max oil refined | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely Glycine max oil refined 200 milligram/1 milliliter conventional release emulsion for infusion (clinical drug) | Has manufactured dose form | Emulsion for infusion | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely Glycine max oil refined 200 milligram/1 milliliter conventional release emulsion for infusion (clinical drug) | Is a | Product containing only Glycine max oil refined in parenteral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely Glycine max oil refined 200 milligram/1 milliliter conventional release emulsion for infusion (clinical drug) | Is a | Product containing precisely Glycine max oil refined 200 milligram/1 milliliter conventional release emulsion for infusion and/or injection (clinical drug) | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR